Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2

被引:124
作者
Foot, Natalie J. [1 ]
Dalton, Hazel E. [1 ]
Shearwin-Whyatt, Linda M. [1 ]
Dorstyn, Loretta [1 ]
Tan, Seong-Seng [2 ]
Yang, Baoli [3 ]
Kumar, Sharad [1 ]
机构
[1] Hanson Inst, Dept Haematol, Adelaide, SA 5000, Australia
[2] Howard Florey Inst, Brain Dev Grp, Melbourne, Vic, Australia
[3] Univ Iowa, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA
基金
英国医学研究理事会;
关键词
D O I
10.1182/blood-2008-04-150953
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Many ion channels and transporters are regulated by ubiquitination mediated by the Nedd4 family of HECT-type ubiquitin ligases (E3s). These E3s commonly interact with substrates via their WW domains that bind to specific motifs in target proteins. However, not all potential targets of these E3s contain WW-binding motifs. Therefore, accessory proteins may mediate the interaction between Nedd4 family members and their targets. Here we report that the divalent metal ion transporter DMT1, the primary nonheme iron transporter in mammals, is regulated by ubiquitination mediated by the Nedd4 family member WWP2. DMT1 interacts with 2 WW domain-interacting proteins, Ndfip1 and Ndfip2, previously proposed to have roles in protein trafficking. This promotes DMT1 ubiquitination and degradation by WWP2. Consistent with these observations, Ndfip1(-/-) mice show increased DMT1 activity and a concomitant increase in hepatic iron deposition, indicating an essential function of Ndfip1 in iron homeostasis. This novel mechanism of regulating iron homeostasis suggests that Ndfips and WWP2 may contribute to diseases involving aberrant iron transport. (Blood. 2008; 112: 4268-4275)
引用
收藏
页码:4268 / 4275
页数:8
相关论文
共 41 条
[1]
Ubiquitylation of ion channels [J].
Abriel, H ;
Staub, O .
PHYSIOLOGY, 2005, 20 :398-407
[2]
Iron homeostasis: Insights from genetics and animal models [J].
Andrews, NC .
NATURE REVIEWS GENETICS, 2000, 1 (03) :208-217
[3]
Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload [J].
Beaumont, C ;
Delaunay, J ;
Hetet, G ;
Grandchamp, B ;
de Montalembert, M ;
Tchernia, G .
BLOOD, 2006, 107 (10) :4168-4170
[4]
Beilby JP, 1999, CLIN CHEM, V45, P573
[5]
Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice [J].
Canonne-Hergaux, F ;
Zhang, AS ;
Ponka, P ;
Gros, P .
BLOOD, 2001, 98 (13) :3823-3830
[6]
The regulation of cellular iron metabolism [J].
Chua, Anita C. G. ;
Graham, Ross M. ;
Trinder, Debbie ;
Olynyk, John K. .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2007, 44 (5-6) :413-459
[7]
Pathology of hepatic iron overload [J].
Deugnier, Yves ;
Turlin, Bruno .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (35) :4755-4760
[8]
Iron uptake and metabolism in the new millennium [J].
Dunn, Louise L. ;
Rahmanto, Yohan Suryo ;
Richardson, Des R. .
TRENDS IN CELL BIOLOGY, 2007, 17 (02) :93-100
[9]
A field guide to ubiquitylation [J].
Fang, S ;
Weissman, AM .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (13) :1546-1561
[10]
Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383